… warfarin, several AF guidelines have regarded NOACs (… patients with non-valvular AF
received at least off-label underdose or overdose of one NOAC (dabigatran, rivaroxaban, apixaban…

… to be effective in patients with non valvular chronic AF, and … -dose warfarin compared with
aspirin/low-dose warfarin, with … acid, dabigatran, rivaroxaban and apixaban were associated …

… between warfarin and NOACs in non-valvular atrial fibrillation (NVAF) … in non-valvular atrial
fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin …

… hemorrhage than white populations, low-dose rivaroxaban (ie, … of rivaroxaban was >90%,
whereas that of dabigatran was 35%… warfarin in Japanese patients with atrial fibrillation—the J-…

… in patients with atrial fibrillation (AF) at significant stroke risk. … bleeding (including intracranial
hemorrhage) than warfarin (2… could receive rivaroxaban, apixaban, or dabigatran (the …

… of rivaroxaban, apixaban, and edoxaban (but not dabigatran) … bridging approach with UFH
or low-dose dabigatran, in view of … with non-valvular (NV) AF who initialized warfarin, only 40.4…

… with non-valvular atrial fibrillation (NVAF). This was a retrospective … Recent studies suggested
that low-dose rivaroxaban … and DOAC, including dabigatran, rivaroxaban, apixaban, and …

… twice daily for dabigatran, 20 mg once daily for rivaroxaban, 5 mg twice daily for apixaban,
and … a once-daily low dose of edoxaban (15 mg) in elderly Japanese patients, was superior to …

… (dabigatran) and three-factor Xa inhibitors (rivaroxaban, … data suggest that apixaban is safest,
and rivaroxaban is likely … with 3 F-PCCs (which is not available worldwide) plus low-dose …

… Vitamin K antagonists (VKAs) such as warfarin had long … could receive either rivaroxaban,
apixaban, or dabigatran at the … %) DOAC patients received low-dose apixaban, appropriately …